*** Proof of Product ***
Exploring the Essential Features of “Elizabeth Nielson – Psychedelic Harm Reduction and Integration in Clinical Practice – PESI”
Please see the full list of alternative group-buy courses available here: https://lunacourse.com/shop/Speaker: Elizabeth Nielson, PhD
Duration: 1 Hour
Copyright: Jul 27, 2022
Media Type: Digital Seminar
Description
What do you do when a client lets you know they are going to use psychedelics on their own, as part of a ceremony, spiritual practice or because they’ve heard it can help them? Is there anything you can do to help reduce harm? And what about micro-dosing, which is gaining popularity?
Psychedelic Harm Reduction and Integration (PHRI) is a transdiagnostic and transtheoretical approach that YOU as a mental health professional can take to having conversations with people who have taken psychedelics in clinical or non-clinical settings, or who are seeking help at any stage of psychedelic use. This recording will cover the core concepts of PHRI and its applications, including discussions about microdosing, responding to requests for referrals to non-licensed providers, and working with difficult experiences.
Speaker
Elizabeth Nielson, PhD
Dr. Elizabeth Nielson, PhD, is a co-founder of Fluence and a psychologist with a focus on developing psychedelic medicines as empirically supported treatments for PTSD, substance use problems, and mood disorders. Dr. Nielson is a Site Co-Principal Investigator and therapist for an FDA approved Phase 3 clinical trial of MDMA-assisted Psychotherapy for Post-Traumatic Stress Disorder and has served as a therapist on FDA approved clinical trials of psilocybin-assisted treatment of alcohol use disorder, psilocybin-assisted treatment of treatment resistant depression, and earlier phase 2 and 3 trials of MDMA-assisted psychotherapy. Through Fluence, she provides continuing education and training programs for therapists who wish to engage in integration of psychedelic experiences in clinical settings. Her research includes qualitative and mixed-methods projects designed to further understand the phenomenology and mechanisms of change in psychedelic-assisted therapy, including the experiences of trial participants and of the therapists themselves. Having completed an NIH postdoctoral fellowship at NYU, she has published and presented on topics of psychedelic therapist training, therapists’ personal experience with psychedelics, and including psychedelic integration in group and individual psychotherapy.
Speaker Disclosures:
Financial: Elizabeth Nielson is the co-founder of Fluence and has employment relationships with Columbia University Irving Medical Center, New York State Psychiatric Institute, and MAPS NY Private Practice Research Site. She receives a speaking honorarium from PESI, Inc. She has no relevant financial relationships with ineligible organizations.
Non-financial: Elizabeth Nielson is the founding member and an advisory board member of the Psychedelic Medicine Association. She is a member of the American Psychological Association and the International Society for Research on Psychedelics.
Objectives
- Differentiate Psychedelic Harm Reduction and Integration from Psychedelic-assisted Therapy. Â
- Determine ways to intervene with clients who are using or micro-dosing psychedelics.
- Assess four theoretical pillars of the Psychedelic Harm Reduction and Integration model. Â
- Integrate Psychedelic Harm Reduction and Integration into the larger picture of psychedelic-assisted therapies.
Outline
- The differences between psychedelic assisted therapies & harm reduction interventionsÂ
- The Four foundations of psychedelic harm reduction interventionsÂ
- A model for integration of psychedelic applicationsÂ
- The issue of micro-dosing among clientsÂ
- When clinicians are asked for referrals to non-licensed providersÂ
- Working with difficult psychedelic experiences in psychotherapyÂ
Target Audience
Other Behavioral Health Professionals
Counselors
Marriage & Family Therapists
Nurses
Nurse Practitioners
Physicians
Psychologists
Social Workers